Labetalol
- Product NDC
- 10135-642
- 11-digit product format
- 101350642
- Labeler code
- 10135
- Product ID
- 10135-642_d283e94b-266e-40c6-bee9-856ce2d6ceb9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Labetalol
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA075215
- Marketing category
- ANDA
- Marketing start
- 2018-04-01
- Marketing end
- 0000-00-00
- Substance
- LABETALOL
- Active strength
- 200 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-642-01 | Labetalol | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-642 | LABETALOL TABLET, FILM COATED [MARLEX PHARMACEUTICALS INC] | 1 | Legacy NDC, 1 package rows | 20180405_b4c13317-88eb-48f2-aba2-50f01c8ff938.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10135-642-01 | 10135064201 | 100 in 1 BOTTLE, PLASTIC | Historical |